Welcome to TERM

Tissue Engineering and Regenerative Medicine

The Tissue Engineering and Regenerative Medicine (TERM) group is based at the Biomedical Center (BMC), Faculty of Medicine, Department of Clinical Sciences, Orthopaedics, Lund University. Our research is translational with focus on repair, regenerate and replace diseased tissues. Engineered tissues and methods developed by our group will improve the quality of life of patients and potentially alleviate the burden on the public healthcare system. Special area of interest is musculoskeletal conditions.

The TERM Lund lab has close collaboration with Skåne University Hospital and major university centers globally. The group has during the last three years received 2.5 million Euro in competitive grants.

Core Group
Professor Lars Lidgren. Professor Magnus Tägil, Deepak Raina and Jintian Huang
Focus Areas
Biomaterials, Fracture Healing, Orthopedic Implants, Osteoporosis, Drug Delivery In Cancer and Infections
Biomedical Center (BMC),Lund University, Sölvegatan 17, 223 62 Lund

Disclaimer: This is an external website from the Tissue engineering and Regenerative Medicine (TERM) group , working at the Lund University.

Recent Updates

ORS 2023 Annual meeting

Our group presented their research work in the area of tumor, fracture fixation and bone infection. Deepak Raina was also nominated for the New Investigator Recognition Award (NIRA).

Study published in Journal of Bone and Joint Infection
Study published in Frontiers in Bioengineering and Biotechnology

Safety study titled Longitudinal in vivo bio distribution of nano and micro sized hydroxyapatite particles implanted in a bone defect’  published on Frontiers in Bioengineering and Biotechnology.

Article published by the Medical Faculty at Lund University

The Medical Faculty at Lund University published a news article highlighting our research work on treatment of osteosarcoma.


Research Areas

Bone Regeneration

A regenerative medicine approach for fragility fractures, improving implant anchorage leading to less fixation failures, re-operations


Targeted delivery of anti-tumor drugs using bone minerals as a recruiting platform.

Bone Infection

Avoiding infection recurrence by bio-modulation of hydroxyapatite.

Selected presentations and posters